Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
34.17
-1.43 (-4.02%)
At close: Oct 16, 2025, 4:00 PM EDT
32.64
-1.53 (-4.48%)
Pre-market: Oct 17, 2025, 8:01 AM EDT

Stoke Therapeutics Stock Forecast

Stock Price Forecast

The 6 analysts that cover Stoke Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $30.83, which forecasts a -9.77% decrease in the stock price over the next year. The lowest target is $22 and the highest is $39.

Price Target: $30.83 (-9.77%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$22$30.83$35$39
Change-35.62%-9.77%+2.43%+14.14%

Analyst Ratings

The average analyst rating for Stoke Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingMay '25Jun '25Jul '25Aug '25Sep '25Oct '25
Strong Buy334445
Buy221222
Hold000000
Sell000000
Strong Sell000000
Total555667

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
BTIG
BTIG
Strong Buy
Maintains
$28$39
Strong BuyMaintains$28$39+14.14%Oct 13, 2025
Needham
Needham
Strong Buy
Maintains
$22$35
Strong BuyMaintains$22$35+2.43%Oct 10, 2025
Chardan Capital
Chardan Capital
Strong Buy
Maintains
$24
Strong BuyMaintains$24-29.76%Aug 13, 2025
Wedbush
Wedbush
Buy
Maintains
$16$22
BuyMaintains$16$22-35.62%Aug 13, 2025
Jefferies
Jefferies
Strong Buy
Initiates
$30
Strong BuyInitiates$30-12.20%Jul 18, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
188.82M
from 36.56M
Increased by 416.54%
Revenue Next Year
32.26M
from 188.82M
Decreased by -82.92%
EPS This Year
0.30
from -1.65
EPS Next Year
-2.88
from 0.30
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
--12.41M8.78M36.56M188.82M32.26M
Revenue Growth
----29.22%316.34%416.54%-82.92%
EPS
-1.56-2.34-2.60-2.38-1.650.30-2.88
EPS Growth
-------
Forward PE
-----115.32-
No. Analysts
-----1313
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High216.1M73.5M
Avg188.8M32.3M
Low174.8M11.8M

Revenue Growth

Revenue Growth20252026202720282029
High
491.1%
-61.1%
Avg
416.5%
-82.9%
Low
378.2%
-93.8%

EPS Forecast

EPS20252026202720282029
High0.45-2.39
Avg0.30-2.88
Low-0.10-3.58

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.